MDXG MIMEDX GROUP, INC.

NEUTRAL Impact: 3/10 DEFA14A
Horizon weeks Filed Apr 29, 2026 Processed 1mo ago SEC 0001376339-26-000037
Proxy solicitation materials
Latest settled — T+20d
MDXG ▲ +9.23% at T+20d
NEUTRAL call ✓ call won +9.23% · α vs SPY +4.26% · entry $3.36 → $3.67
Next anchor: T+60d in 6w
Last close $3.60 (close Jun 12) · +7.14% from $3.36 entry
Entry anchored
Apr 29, 03:59 PM ET
via Databento tick
T+1d
0.00%
call 0.00% · α -0.22%
$3.36
settled 7w ago
T+5d
+8.93%
call +8.93% · α +7.20%
$3.66
settled 6w ago
T+20d
+9.23%
call +9.23% · α +4.26%
$3.67
settled 18d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

MiMedx Group filed a DEFA14A (additional definitive proxy soliciting materials). The substantive content of the filing is unavailable as only cover page and encoded graphic images were provided. The filing follows an April 16 8-K announcing a cost reduction initiative expected to generate $40 million in annualized savings, including elimination of the COO role. Without readable proxy content, the specific proposals or solicitation matters cannot be determined.

Actionable Insight

Monitor for the definitive proxy statement (DEF 14A) and any disclosure of shareholder proposals or voting items. The recent cost reduction program may be a precursor to activist engagement or management restructuring proposals.

Key Facts

  • Filing type: DEFA14A (additional definitive proxy soliciting materials)
  • Filed April 29, 2026, following an April 16, 2026 8-K announcing cost reduction and executive changes
  • Prior 8-K projected $40 million in annualized savings and a one-time $4 million restructuring charge
  • Proxy statement content (definitive additional materials) not available in parsed text form

Financial Impact

Not specified

Risk Factors

  • Potential activist campaign or shareholder vote outcome uncertainty
  • Restructuring may impact near-term revenue growth

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
92% bullish (12 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001376339-26-000037
Document: 0001376339-26-000037-index-headers.html0001376339-26-000037
Document: 0001376339-26-000037-index.html0001376339-26-000037
Document: 0001376339-26-000037.txt0001376339-26-000037
4 reports for MDXG
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MDXG — sortable, filterable
Type Now
Jun 2, 2026
13d ago
Court Ruling
BULLISH ★ 5/10
$3.57 $3.61▲ +1.12%▲ +1.81%$3.60 (+0.84%)
Apr 29, 2026
6w ago
DEFA14A
NEUTRAL ★ 3/10
$3.36 $3.36· 0.00%▼ −0.22%$3.60 (+7.14%)
Apr 22, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$3.31 $3.35▲ +1.21%▲ +1.60%$3.60 (+8.76%)
Apr 16, 2026
8w ago
8-K
BEARISH ★ 7/10
$3.43 $3.42▲ +0.29%▲ +1.51%$3.60 (−4.96%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 4h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access